Garcinia Biflavonoid 1 Improves Lipid Metabolism in HepG2 Cells via Regulating PPARα |
| |
| Authors: | Hai-Xin Chen Fan Yang Xin-Qian He Ting Li Yong-Zhi Sun Jian-Ping Song Xin-An Huang Wen-Feng Guo |
| |
| Institution: | 1.Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China; (H.-X.C.); (F.Y.); (X.-Q.H.); (T.L.); (Y.-Z.S.); (J.-P.S.);2.The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou 510405, China |
| |
| Abstract: | Garcinia biflavonoid 1 (GB1) is one of the active chemical components of Garcinia kola and is reported to be capable of reducing the intracellular lipid deposition, which is the most significant characteristic of non-alcoholic fatty liver disease. However, its bioactive mechanism remains elusive. In the current study, the lipid deposition was induced in HepG2 cells by exposure to oleic acid and palmitic acid (OA&PA), then the effect of GB1 on lipid metabolism and oxidative stress and the role of regulating PPARα in these cells was investigated. We found that GB1 could ameliorate the lipid deposition by reducing triglycerides (TGs) and upregulate the expression of PPARα and SIRT6, suppressing the cell apoptosis by reducing the oxidative stress and the inflammatory factors of ROS, IL10, and TNFα. The mechanism study showed that GB1 had bioactivity in a PPARα-dependent manner based on its failing to improve the lipid deposition and oxidative stress in PPARα-deficient cells. The result revealed that GB1 had significant bioactivity on improving the lipid metabolism, and its potential primary action mechanism suggested that GB1 could be a potential candidate for management of non-alcoholic fatty liver disease. |
| |
| Keywords: | garcinia biflavonoid 1 PPARα lipid metabolism fatty acid oxidation |
|
|
